Pregabalin does not appear to raise blood sugar in any clinically meaningful way. In pooled data from 11 randomized controlled trials of pregabalin at doses ranging from 150 to 600 mg per day, the drug was not associated with significant changes in fasting glucose or long-term blood sugar control (HbA1c) compared to placebo. This held true even in patients who already had diabetes. The concern is understandable, especially since pregabalin is one of the most commonly prescribed medications for diabetic nerve pain, but the evidence is reassuring.
What the Clinical Trial Data Shows
The most thorough look at this question comes from a pooled analysis of 11 double-blind trials involving patients with painful diabetic peripheral neuropathy, the exact population where blood sugar effects would matter most. Across doses of 150, 300, and 600 mg per day, pregabalin produced no clinically meaningful changes in HbA1c, fasting glucose, cholesterol, or triglycerides.
There was one small statistical finding: the 300 mg per day dose was associated with an HbA1c increase of 0.11% compared to placebo. To put that in perspective, HbA1c is measured on a scale where a full 1% change represents a major shift in blood sugar control. A 0.11% difference is tiny, well within normal fluctuation, and not something that would change your diabetes management. Interestingly, this bump didn’t show up at the higher 600 mg per day dose or in patients on flexible dosing, which makes it even less likely to reflect a real drug effect.
Animal and cell studies have also looked at this directly. In one study, neither short-term nor long-term pregabalin use significantly altered blood glucose levels. The researchers noted that unlike some other seizure medications, pregabalin shows “no obvious effects on blood glucose levels.”
Why Weight Gain Raises the Question
The reason many people worry about pregabalin and blood sugar is weight gain. It is one of the most common side effects. In clinical trials for diabetic nerve pain, patients on pregabalin gained an average of 1.6 kg (about 3.5 pounds) compared to 0.3 kg on placebo. The weight gain is dose-dependent, meaning higher doses and longer use tend to produce more of it.
Weight gain, especially around the midsection, can reduce insulin sensitivity over time and push blood sugar higher. This is a well-established pathway to worsening metabolic control. So the theoretical concern is legitimate: if pregabalin causes you to gain a significant amount of weight, that could eventually affect your blood sugar indirectly. But in the trials that tracked this, the weight gain that occurred during pregabalin treatment did not translate into meaningful blood sugar changes. The drug itself does not appear to interfere with insulin or glucose metabolism directly.
How Pregabalin Compares to Similar Medications
Pregabalin and gabapentin belong to the same drug class and are often compared. In a retrospective study of patients with diabetic peripheral neuropathy, there was no significant difference in HbA1c levels between the pregabalin and gabapentin groups. Both medications appear to be metabolically neutral in terms of direct blood sugar effects.
Duloxetine, another common treatment for diabetic nerve pain, may actually lower HbA1c. In the same study, duloxetine significantly reduced HbA1c compared to both pregabalin and gabapentin. This led researchers to suggest that duloxetine may be a better fit for patients whose blood sugar is already well controlled (since they have less room for it to drop), while pregabalin and gabapentin are reasonable choices for patients with HbA1c levels above 8.7, where the neutral metabolic profile is an advantage rather than a drawback.
The Overdose Exception
There is one scenario where pregabalin has been linked to elevated blood sugar: massive overdose. In a published case report of a patient who took more than 20 times the upper therapeutic dose, blood glucose on arrival at the emergency department was 15 mmol/L (about 270 mg/dL). This was part of a broader picture of organ stress, including acidosis and elevated potassium, not an isolated blood sugar effect. At normal prescribed doses, this is not a concern.
What This Means if You Have Diabetes
If you’re taking pregabalin for nerve pain and you have diabetes or prediabetes, the existing evidence suggests the drug will not disrupt your blood sugar control. The pooled trial data specifically studied diabetic patients and found no clinically meaningful metabolic changes. That said, weight gain is real and common with this medication. Gaining weight over months or years can gradually affect insulin sensitivity, so keeping an eye on your weight while taking pregabalin is a practical step. Your regular HbA1c checks will also catch any drift in blood sugar control, regardless of the cause.
If you notice your blood sugar readings creeping up after starting pregabalin, the medication itself is unlikely to be the direct cause. It’s worth looking at whether weight gain, dietary changes, reduced physical activity (which can happen when pain improves and routines shift), or other factors might be playing a role.